4
Changes in Ownership
Tango Therapeutics, Inc. Filed Acc 0000899243-22-004604
Options or other derivatives
- Chief Financial Officer acquired 150,000 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
Beckman Daniella · Chief Financial Officer
Table II: Derivative
1 line| Date | Transaction | Shares | Exercise | Expires | Underlying | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| 2022-02-01 | Grant or award : show line 1 in the form Stock Option (Right to Buy) | +150,000 | $9.22 | 2032-02-01 | 150,000 | 150,000 | D |
Loading xslF345X03/doc4.xml…